AIM BIOTECH
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Jun 2023)
What this means for you
This application is over — abandoned 05 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88588339
- Mark type
- Stylized text
- Filed
- 22 Aug 2019
- Published for opposition
- 10 Mar 2020
- Abandoned
- 05 Jun 2023
- Attorney of record
- Donna J. Bunton
Goods and services
- Class 005 — Pharmaceuticals: Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
Owner
- AIM IMMUNOTECH INC., OCALA, FL, US
- AIM IMMUNOTECH INC., OCALA, FL, US
- HEMISPHERX BIOPHARMA, INC., Orlando, FL, US
Prosecution history
- 05 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2022 — SOU EXTENSION 5 GRANTED
- 25 Oct 2022 — SOU EXTENSION 5 FILED
- 02 Nov 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 06 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 May 2022 — SOU EXTENSION 4 GRANTED
- 04 May 2022 — SOU EXTENSION 4 FILED
- 04 May 2022 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2021 — SOU EXTENSION 3 GRANTED
- 04 Nov 2021 — SOU EXTENSION 3 FILED
- 04 Nov 2021 — SOU TEAS EXTENSION RECEIVED